nkiras2 Antibody

What is NKIRAS2 and what cellular functions does it serve?

NKIRAS2, also known as kappaB-Ras2 or KBRAS2, is an atypical Ras-like protein that functions as a potent regulator of NF-kappa-B activity. It primarily acts by preventing the degradation of NF-kappa-B inhibitor beta (NFKBIB) by most signaling pathways, which explains why NFKBIB demonstrates greater resistance to degradation compared to other inhibitors. NKIRAS2 appears to block phosphorylation of NFKBIB and prevent nuclear localization of the p65/RELA NF-kappa-B subunit .

How should researchers interpret variable molecular weights observed for NKIRAS2?

While the calculated molecular weight of NKIRAS2 is approximately 21.5-22 kDa , some antibodies report detecting bands at significantly different weights (e.g., 68 kDa) . This discrepancy may result from:

• Post-translational modifications

• Protein complexes resistant to denaturation

• Splice variants or isoforms

• Non-specific antibody binding

Researchers should validate their specific antibody using positive controls such as recombinant NKIRAS2 protein alongside negative controls and knockdown samples to confirm specificity.

What criteria should guide the selection of an appropriate NKIRAS2 antibody for different applications?

The selection of an appropriate NKIRAS2 antibody depends on the intended application, species of interest, and specific experimental requirements:

For Western Blotting:

• Antibodies with validated WB applications show recommended dilutions ranging from 1:500-1:1000

• Consider antibodies raised against peptides from different regions (e.g., central region or C-terminus) depending on which domain of NKIRAS2 you're investigating

• Validated antibodies have been tested on specific cell lines, including HEK-293 and HepG2 cells

For Immunofluorescence/ICC:

• More stringent dilutions are typically required (1:20-1:200)

• Validated on cell lines such as A431 cells

For Immunoprecipitation:

• Select antibodies specifically validated for IP applications

• Recommended usage: 0.5-4.0 μg antibody for 1.0-3.0 mg of total protein lysate

Reactivity considerations:
Different antibodies show varying reactivity profiles across species:

• Human-only reactivity

• Cross-reactivity with mouse, chicken, and Xenopus

• Human, mouse, and rat reactivity

How can researchers verify NKIRAS2 antibody specificity and optimize experimental conditions?

Antibody validation is critical for reliable results. Consider these approaches:

• Positive Controls:

  • Use recombinant NKIRAS2 protein as a standard

  • Include cell lines with known NKIRAS2 expression (HEK-293, HepG2)

• Negative Controls:

  • Perform siRNA/shRNA knockdown experiments

  • Include isotype control antibodies

  • Use peptide competition assays with the immunizing peptide

• Optimization Strategy:

  • Perform dilution series to determine optimal concentration

  • Test multiple blocking reagents (BSA, milk, commercial blockers)

  • Adjust incubation time and temperature

  • For WB: Test different transfer methods and membrane types

• Validation across applications:

  • Confirm consistency of results across multiple detection methods (e.g., WB and IF)

  • Verify molecular weight matches predicted size (approximately 22 kDa)

How can NKIRAS2 antibodies be used to investigate its role in cancer progression?

Recent studies have implicated NKIRAS2 in tumor suppression mechanisms, particularly in osteosarcoma:

• Expression Analysis:

  • Compare NKIRAS2 expression levels between normal and cancer tissues

  • Correlate expression with clinical outcomes

  • Research has shown NKIRAS2 is downregulated in osteosarcoma cells compared to normal osteoblast cell lines

• Functional Studies:

  • Use NKIRAS2 antibodies to monitor protein levels after gene knockdown or overexpression

  • Recent findings demonstrated that NKIRAS2 knockdown promoted proliferation of osteosarcoma cells, while overexpression inhibited proliferation

  • NKIRAS2 significantly inhibited the invasive capacity of osteosarcoma cells in Transwell assays

• Pathway Analysis:

  • Monitor NF-κB pathway activity in relation to NKIRAS2 expression

  • Investigate post-translational modifications using phospho-specific antibodies

  • Research has identified NKIRAS2 as a target of miR-4492 in osteosarcoma, with miR-4492 downregulating NKIRAS2 expression

• In vivo Studies:

  • NKIRAS2 expression correlates with tumor growth rates in xenograft models

  • Tumors with higher NKIRAS2 expression show decreased proliferation marker PCNA levels

What experimental approaches can effectively elucidate NKIRAS2 interactions with the NF-κB pathway?

Investigating NKIRAS2's role in NF-κB regulation requires specialized techniques:

• Co-immunoprecipitation (Co-IP):

  • Use NKIRAS2 antibodies to pull down protein complexes

  • Analyze interactions with IκBα and IκBβ, focusing on the PEST domains

  • Recommended antibody amount: 0.5-4.0 μg for 1.0-3.0 mg of total protein lysate

• Proximity Ligation Assay (PLA):

  • Visualize protein-protein interactions in situ

  • Combines antibody specificity with signal amplification

  • Particularly useful for detecting transient interactions

• Chromatin Immunoprecipitation (ChIP) Assays:

  • Investigate how NKIRAS2 affects NF-κB binding to target gene promoters

  • Analyze changes in chromatin accessibility

• CRISPR/Cas9 Gene Editing:

  • Generate NKIRAS2 knockout cell lines

  • Introduce mutations in specific domains to dissect functional importance

  • Monitor impacts on NF-κB signaling using validated antibodies

What are the most common technical challenges when working with NKIRAS2 antibodies and how can they be addressed?

What are the optimal methodologies for studying NKIRAS2 gene expression?

For quantitative analysis of NKIRAS2 expression, several approaches are recommended:

• RT-PCR Amplification:

  • Validated primers: 5′-TGGGGCCGAACTGCCCCGA-3′ and 5′-CGTCATCTTGCTGGCCAAGTAGACA-3′ for human NKIRAS2

  • For mouse studies: complement with primers for murine housekeeping genes such as GAPDH (5′-ACCACAGTCCATGCCATCAC-3′ and 5′-TCCACCACCCTGTTGCTGTA-3′)

• Sample Preparation for RNA Extraction:

  • Suspend cells in TRI-reagent (1 mL per sample)

  • Add 0.2 mL chloroform and vortex for 15 seconds

  • Centrifuge and transfer upper layer to fresh tube

  • Precipitate RNA with 3 volumes of ethanol

  • Remove genomic DNA contamination with DNase I treatment

• Correlating Protein and mRNA Expression:

  • Interestingly, research has shown that miR-4492 downregulates NKIRAS2 protein expression without significantly changing NKIRAS2 mRNA levels

  • This suggests post-transcriptional regulation and highlights the importance of analyzing both mRNA and protein levels

How is NKIRAS2 being investigated in non-cancer disease contexts?

While much of the current research focuses on cancer, NKIRAS2's role in regulating NF-κB signaling suggests potential implications in:

• Inflammatory Disorders:

  • Given NF-κB's central role in inflammation, NKIRAS2 may influence inflammatory disease progression

  • Antibodies can be used to assess NKIRAS2 expression in inflammatory tissue samples

• Neurodegenerative Diseases:

  • NKIRAS2 shows expression in brain tissue

  • NF-κB dysregulation has been implicated in various neurodegenerative conditions

  • Research potential roles in neuroinflammatory processes

• Immune Response Regulation:

  • Monitor NKIRAS2 expression in immune cells during activation

  • Investigate potential immunomodulatory functions

What novel techniques are being developed to study NKIRAS2 interactions?

Emerging methodologies for investigating NKIRAS2:

• Protein-RNA Interactions:

  • Recent research identified interactions between SNHG22 (long non-coding RNA) and miR-4492, which targets NKIRAS2

  • RNA immunoprecipitation assays and RNA pull-down assays can validate such interactions

  • Dual-luciferase reporter assays have confirmed that SNHG22 can directly interact with miR-4492 and upregulate NKIRAS2 through competing endogenous RNA activity

• Mass Spectrometry-Based Approaches:

  • Identify novel NKIRAS2 binding partners

  • Characterize post-translational modifications

• Live Cell Imaging:

  • Track NKIRAS2 dynamics in response to NF-κB pathway activation

  • Requires fluorescently tagged NKIRAS2 constructs and validated antibodies for confirmation

• Single-Cell Analysis:

  • Evaluate cell-to-cell variation in NKIRAS2 expression

  • Correlate with NF-κB pathway activity at single-cell resolution